1001.90
0.12%
BOB Capital Markets Ltd.
US and ROW sales grew above our estimates of 5% and 13% respectively, reporting growth of 10% each
Alembic Pharmaceutic.. has an average target of 968.25 from 4 brokers.
More from Alembic Pharmaceuticals Ltd.
Recommended